Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

Aims: Little is known regarding consequences of frailty in patients with acute coronary syndrome (ACS). We assessed the associations of frailty and outcomes in ACS patients who were participating in a clinical trial. Methods and results: The TaRgeted platelet Inhibition to cLarify the Optimal strate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Acute cardiovascular care 2016-06, Vol.5 (3), p.231-242
Hauptverfasser:	White, Harvey D, Westerhout, Cynthia M, Alexander, Karen P, Roe, Matthew T, Winters, Kenneth J, Cyr, Derek D, Fox, Keith AA, Prabhakaran, Dorairaj, Hochman, Judith S, Armstrong, Paul W, Ohman, E Magnus
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - mortality Age Factors Aged Aged, 80 and over Double-Blind Method Female Frail Elderly Health Surveys Humans Male Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - therapeutic use Prognosis Ticlopidine - administration & dosage Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!